Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China · Delayed Price · Currency is CNY 116.50
-4.28 (-3.54%)
Aug 21, 2026, 3:00 PM CST
SHA:688578 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2,679 | 2,189 | 1,430 | 644.17 | 130.52 | 18.27 |
Depreciation & Amortization | 47.14 | 42.21 | 38.61 | 39.39 | 25.25 | 23.46 |
Other Amortization | 2.65 | 2.3 | 1.19 | 0.79 | 1.77 | 2.42 |
Loss (Gain) From Sale of Assets | -0.01 | -0.02 | - | -0.02 | -0.03 | - |
Asset Writedown & Restructuring Costs | 3.27 | 3.27 | 0.01 | 0.03 | 1.71 | -34.53 |
Loss (Gain) From Sale of Investments | -45.81 | -53.99 | -35.58 | -32.58 | -45.01 | -66.01 |
Stock-Based Compensation | 15.49 | 25.43 | 78.26 | - | - | - |
Provision & Write-off of Bad Debts | 0.39 | -0.04 | 0.16 | -0.71 | 1.36 | 0.5 |
Other Operating Activities | -57.3 | -42.98 | -45.21 | -36.02 | -29.53 | 4.72 |
Change in Accounts Receivable | -100.17 | -13.63 | -186.03 | -163.84 | -108.57 | 8.22 |
Change in Inventory | -44.25 | -38.29 | 32.39 | -30.88 | -10.62 | -12.34 |
Change in Accounts Payable | 179.65 | 217.76 | 238.62 | 184.14 | 67.38 | 10.89 |
Change in Other Net Operating Assets | -0.64 | - | - | 75.03 | 68.91 | 73.69 |
Operating Cash Flow | 2,674 | 2,323 | 1,566 | 674.65 | 91.63 | 29.29 |
Operating Cash Flow Growth | 38.69% | 48.31% | 132.12% | 636.28% | 212.82% | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -126.31 | -186 | -270.22 | -67.88 | -143.83 | -192.25 |
Sale of Property, Plant & Equipment | - | - | - | - | 0 | - |
Investment in Securities | -2,143 | -1,943 | -1,645 | 1,416 | 81.63 | 599.99 |
Other Investing Activities | 82.95 | 92.9 | 80.08 | -1,255 | -342.02 | -168.56 |
Investing Cash Flow | -2,187 | -2,036 | -1,835 | 92.75 | -404.21 | 239.19 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 0.1 | - | - | - | - |
Total Debt Issued | 0.06 | 0.1 | - | - | - | - |
Long-Term Debt Repaid | - | -3.01 | -2.38 | -2.58 | -4.87 | -8.97 |
Total Debt Repaid | -3.26 | -3.01 | -2.38 | -2.58 | -4.87 | -8.97 |
Net Debt Issued (Repaid) | -3.2 | -2.91 | -2.38 | -2.58 | -4.87 | -8.97 |
Common Dividends Paid | -450 | -360 | -292.5 | - | - | - |
Other Financing Activities | -0.14 | -0.11 | -0.16 | 0.37 | 1.19 | -8 |
Financing Cash Flow | -453.34 | -363.02 | -295.05 | -2.21 | -3.69 | -16.97 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.81 | -1.09 | 2.84 | 4.35 | 17.17 | -3.38 |
Net Cash Flow | 33.62 | -77.34 | -561.36 | 769.55 | -299.1 | 248.13 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 2,548 | 2,137 | 1,296 | 606.77 | -52.21 | -162.95 |
Free Cash Flow Growth | 55.97% | 64.88% | 113.56% | - | - | - |
Free Cash Flow Margin | 41.55% | 41.19% | 36.42% | 30.06% | -6.60% | -30.74% |
Free Cash Flow Per Share | 5.65 | 4.74 | 2.88 | 1.35 | -0.12 | -0.36 |
Levered Free Cash Flow | 1,552 | 1,453 | 823.28 | 378.35 | -56.71 | -120.89 |
Unlevered Free Cash Flow | 1,552 | 1,453 | 823.32 | 378.45 | -56.5 | -120.51 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 1,210 | 1,002 | 566.32 | 243.72 | 12.82 | -15.03 |
Change in Working Capital | 29.98 | 157.24 | 98.74 | 59.58 | 5.59 | 80.45 |